Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (721-730 of 829) with videos related to

Pageof 83
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapyNatasha B Leighl, Heather L Shepherd, Phyllis N Butow, et al.
Cancer Medicine|January 12, 2017
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survivalOlusola O Faluyi, Lawson Eng, Xin Qiu, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 15, 2015
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trialA M Horgan, G Darling, R Wong, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 20, 2021
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant TherapyA M Elamir, S Hutchinson, H Albaba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040I Melero, T Yau, Y-K Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.
Annals of Surgery|October 17, 2024
Vascular Resection for Pancreas Cancer - 10-year Experience from a Single High Volume-centerDavid Henault, Holden Kunde, Cody Zatzman, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Pageof 83

Showing results (721-730 of 829) with videos related to

Sort By:
Pageof 83
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapyNatasha B Leighl, Heather L Shepherd, Phyllis N Butow, et al.
Cancer Medicine|January 12, 2017
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survivalOlusola O Faluyi, Lawson Eng, Xin Qiu, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 15, 2015
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trialA M Horgan, G Darling, R Wong, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 20, 2021
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant TherapyA M Elamir, S Hutchinson, H Albaba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040I Melero, T Yau, Y-K Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.
Annals of Surgery|October 17, 2024
Vascular Resection for Pancreas Cancer - 10-year Experience from a Single High Volume-centerDavid Henault, Holden Kunde, Cody Zatzman, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Pageof 83